These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. [Middle molecules and the problem of endogenous intoxication in critical states of various etiologies]. Vladyka AS; Levitskiĭ ER; Poddubnaia LP; Gabriélian NI Anesteziol Reanimatol; 1987; (2):37-42. PubMed ID: 3300433 [No Abstract] [Full Text] [Related]
35. Mathematical formulation of the dialysis index for middle molecules, D1(MM). Milutinovic J; Babb AL; Eschbach JW; Follette WC; Graefe U; Strand MJ; Scribner BH Artif Organs; 1978 Feb; 2(1):51-4. PubMed ID: 687021 [No Abstract] [Full Text] [Related]
36. [Diagnostic value of determining middle molecules in the blood plasma in nephrological diseases]. Gabriélian NI; Dmitriev AA; Kulakov GP; Melikian AM; Shcherbaneva OI Klin Med (Mosk); 1981 Oct; 59(10):38-42. PubMed ID: 7311409 [No Abstract] [Full Text] [Related]
37. [Examination of lymphokines in patients with hemodialysis (author's transl)]. Löcsey L; Kálmán K; Hauck M; Kakuk G Allerg Immunol (Leipz); 1979; 25(3):211-7. PubMed ID: 162030 [TBL] [Abstract][Full Text] [Related]
38. [Study of middle molecules with positive reaction to ninhydrin present in uremic and normal blood and their isolation]. Buzio C; Dall'Aglio PP; Delmonte G; Montagna G; Migone L Minerva Nefrol; 1979; 26(1):45-8. PubMed ID: 471320 [No Abstract] [Full Text] [Related]
39. Plasma middle molecules in asymptomatic and "sick" uremic patients. Asaba H; Bergström J; Fürst P; Johnson C; Yahiel V Artif Organs; 1981; 4 Suppl():137-42. PubMed ID: 7295080 [TBL] [Abstract][Full Text] [Related]
40. Uremic toxins inhibit the platelet malonyldialdehyde production rate. Tanaka H; Itoh S; Yamagami S; Kishimoto T; Maekawa M; Ringoir S Adv Exp Med Biol; 1987; 223():115-8. PubMed ID: 3447425 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]